促胃肠动力药的进展与临床评价  

Progress of Gastroprokinetic Agents:Clinical Evaluation

作　　者：张石革[1] 陈瑞红[1] 

机构地区：[1]北京大学第四临床医学院北京积水潭医院,北京市100035

出　　处：《中国医院用药评价与分析》2009年第7期487-489,共3页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:了解胃肠道促动力剂的最新动态。方法:查阅国内外文献,结合基础研究成果对各种药物在治疗消化不良中的地位和疗效进行讨论。结果及结论:胃肠促动力药具有疗效好、不良反应少等特点,除用于消化不良外,尚可治疗食管反流性疾病、慢性胃炎、便秘等,在胃肠疾病的治疗中显示出良好的前景。OBJECTIVE：To study the latest development of the gastroprokinetic agents.METHODS：The role and curative efficacy of different drugs in the treatment of dyspepsia were discussed by reviewing literature both at home and abroad combined with the results of basic research.RESULTS ＆ CONCLUSION：Gastroprokinetic agents are characterized by good efficacy but few adverse reactions.They are not only used for dyspepsia but also for the treatment of gastroesophageal reflux disease,chronic gastritis,constipation etc,and they showed promising future in the treatment of gastrointestinal diseases.

关 键 词：胃肠促动力药 消化不良 进展 评价 

分 类 号：R975.1[医药卫生—药品]